康宁杰瑞制药-B(09966)发布中期业绩 期内溢利2157.5万元 同比扭亏为盈

Group 1 - The company reported a revenue of 319 million RMB for the six months ending June 30, 2025, representing a year-on-year increase of 84.05% [1] - The company achieved a profit of 21.575 million RMB during the period, compared to a loss of 44.896 million RMB in the same period last year, indicating a turnaround to profitability [1] - The basic earnings per share for the company were 0.02 RMB [1]